Filing Details
- Accession Number:
- 0000899243-22-038230
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2022-12-12 16:05:12
- Reporting Period:
- 2021-12-08
- Accepted Time:
- 2022-12-12 16:05:12
- Original Submission Date:
- 2021-12-08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1704292 | Zai Lab Ltd | ZLAB | Biological Products, (No Disgnostic Substances) (2836) | MA |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1021041 | Peter Wirth | C/O Zai Lab Limited 314 Main Street, 4Th Floor, Suite 100 Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
American Depositary Shares | Acquisiton | 2021-12-08 | 4,000 | $71.36 | 4,000 | No | 4 | P | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Trust |
Footnotes
- Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
- On December 8, 2021, the Reporting Person filed a Form 4 that inadvertently reported that the Reporting Person acquired ADSs directly. This amendment reflects the indirect ownership of the acquired ADSs.